Amgen Inc.
LYOPHILIZED VIRUS FORMULATIONS

Last updated:

Abstract:

Provided herein is a powder comprising a live, attenuated virus, recombinant human serum albumin (rHSA), a sugar other than lactose, a sugar alcohol, a source of phosphate, a source of chloride, wherein the composition is substantially free of lactose, gelatin, antibiotic, and free amino acids. In exemplary aspects, the powder is a lyophilizate of a liquid composition. Related liquid compositions, methods of preparing an oncolytic virus for administration and methods of treating melanoma are also provided herein.

Status:
Application
Type:

Utility

Filling date:

27 Dec 2019

Issue date:

23 Jun 2022